Edition:
Deutschland

Fresenius Medical Care AG & Co KGaA (FMEG.DE)

FMEG.DE on Xetra

70.82EUR
27 Nov 2020
Change (% chg)

€0.58 (+0.83%)
Prev Close
€70.24
Open
€70.10
Day's High
€70.82
Day's Low
€69.90
Volume
437,779
Avg. Vol
577,251
52-wk High
€81.10
52-wk Low
€53.50

Select another date:

Fri, Nov 27 2020

Photo

Swiss drugmaker Vifor had bid interest but talks halted - sources

LONDON/ZURICH Swiss drugmaker Vifor Pharma had a recent takeover approach from at least one private equity firm, but talks were halted due to differences over price, two sources familiar with the situation said.

UPDATE 1-Swiss drugmaker Vifor had bid interest but talks halted -sources

LONDON/ZURICH, Nov 27 Swiss drugmaker Vifor Pharma had a recent takeover approach from at least one private equity firm, but talks were halted due to differences over price, two sources familiar with the situation said.

Photo

Swiss drugmaker Vifor had bid interest but talks halted: sources

LONDON/ZURICH Swiss drugmaker Vifor Pharma had a recent takeover approach from at least one private equity firm, but talks were halted due to differences over price, two sources familiar with the situation said.

Swiss drugmaker Vifor had bid interest but talks halted -sources

LONDON/ZURICH, Nov 27 Swiss drugmaker Vifor Pharma had a recent takeover approach from at least one private equity firm, but talks were halted due to differences over price, two sources familiar with the situation said.

UPDATE 2-Germany's Fresenius beats Q3 profit forecasts on hospitals, dialysis

* Other regions, segments offset lower sales in North America

Swedish dialysis firm Diaverum targets IPO in November, sources say

FRANKFURT European buyout firm Bridgepoint is preparing to launch a stock market listing of its dialysis clinic operator Diaverum in Stockholm in November, assuming no major decline in broader stock markets, people close to the matter said.

Swedish dialysis firm Diaverum targets IPO in November, sources say

FRANKFURT, Oct 29 European buyout firm Bridgepoint is preparing to launch a stock market listing of its dialysis clinic operator Diaverum in Stockholm in November, assuming no major decline in broader stock markets, people close to the matter said.

Photo

Germany's Fresenius net income beats on strong dialysis, drugs units

German healthcare group Fresenius SE & Co third-quarter net income beat expectations on Thursday, buoyed by strong earnings at its dialysis unit, recovery in generic drugs and a rise in elective procedures at its hospitals.

Fresenius Medical Care Q3 net income beats on strong operations

Oct 29 German dialysis specialist Fresenius Medical Care beat third-quarter net income expectations on Thursday, as it was able to maintain operations and minimize risk for its patients during the COVID-19 pandemic.

Germany's Fresenius Q3 net income beats on strong earnings at dialysis, drugs units

Oct 29 German healthcare group Fresenius SE & Co beat third-quarter net income expectations on Thursday, buoyed by strong earnings at its dialysis unit, recovery in generic drugs and increased number elective procedures at its hospitals.

Select another date: